怀孕和哺乳期相关的骨质疏松性脊柱骨折:一个病例报告
Wenhua Lan1, Zhiliang Guo2, Yongtian Jiang2
1Department of General Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.
The American journal of case reports
|November 5, 2025
概括
怀孕和哺乳期相关的骨质疏松症 (PLO) 是未被认可的. 低BMI是一个关键的危险因素. 在此案例研究中,双酸盐在改善骨矿物质密度 (BMD) 上显示出有限的有效性.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 整形外科 整形外科 整形外科
背景情况:
- 怀孕和哺乳相关的骨质疏松症 (PLO) 是一种罕见的疾病,与骨代谢障碍和低体重指数 (BMI) 等危险因素有关.
- 临床意识有限,缺乏标准化指导方针,导致PLO的诊断和治疗延迟.
- 这一案例突显了在患有PLO和低BMI的患者中延迟诊断和有限的治疗疗效.
研究的目的:
- 在患有低BMI的患者中报告怀孕和哺乳相关骨质疏松症 (PLO) 的情况.
- 讨论PLO的诊断挑战和治疗结果.
- 强调将低BMI视为PLO的危险因素的重要性.
主要方法:
- 一个31岁的女性低BMI呈现PLO症状的病例报告.
- 诊断评估包括磁共振成像 (MRI) 检测脊椎骨折和骨矿物质密度 (BMD) 测试.
- 治疗包括停止母乳养,补充和维生素D (CaD),双酸盐治疗以及胸椎腰椎骨架.
主要成果:
- 该患者在经历延迟治疗和误诊后被诊断出患有严重的骨质疏松症和PLO.
- 虽然治疗改善了疼痛,但在19个月的随访期间,双酸盐在改善该低BMI患者的BMD方面表现出有限的有效性.
- 发现维生素D缺乏,而水平正常.
结论:
- 怀孕和哺乳期相关的骨质疏松症 (PLO) 仍然未得到充分承认,低BMI是显著的风险因素.
- 目前的治疗方法,包括双酸盐,在改善低BMI的PLO患者的BMD方面可能有效性有限.
- 多中心研究对于制定PLO标准化诊断和治疗指南至关重要.
更多相关视频
04:19Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
1.1K
12:25C-arm-Free Simultaneous OLIF51 and Percutaneous Pedicle Screw Fixation in a Single Lateral Position
Published on: September 16, 2022
4.5K
相关概念视频
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
